Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Resolution of Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction After Switching From Fluvoxamine to Fluoxetine

Evidence

J Clin Psychopharmacol. 2022 Nov 29. doi: 10.1097/JCP.0000000000001636. Online ahead of print.

NO ABSTRACT

PMID:36445984 | DOI:10.1097/JCP.0000000000001636

Document this CPD Copy URL Button

Google

Google Keep Add to Google Keep

LinkedIn Share Share on Linkedin Share on Linkedin

Estimated reading time: 1 minute(s)

Latest: Psychiatryai.com #RAISR4D

Real-Time Evidence Search [Psychiatry]

Resolution of Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction After Switching From Fluvoxamine to Fluoxetine

🌐 90 Days

Evidence Blueprint

Resolution of Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction After Switching From Fluvoxamine to Fluoxetine

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

Save Evidence Blueprint

Save as PDF

Resolution of Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction After Switching From Fluvoxamine to Fluoxetine

🌐 365 Days

close chatgpt icon
ChatGPT

Enter your request.